413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors

413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors

Bibliographic Details
Main Authors:	Thomas Davis, Jessica Flechtner, Mara Shainheit, Devin Champagne, Gabriella Santone, Syukri Shukor, Ece Bicak, Samuel Tipps, Li Xue
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors
by: Thomas Davis, et al.
Published: (2020-11-01)

Neoantigens elicit T cell responses in breast cancer
by: Takafumi Morisaki, et al.
Published: (2021-06-01)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
by: Lijin Li, et al.
Published: (2021-04-01)

149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches
by: Manish Jain, et al.
Published: (2020-11-01)

Expediente 41.3
by: Cadernos de Tradução
Published: (2021-10-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Determinants for Neoantigen Identification
by: Andrea Garcia-Garijo, et al.
Published: (2019-06-01)

Clinical evaluation of 413 Thalassemic patients
by: Korosdari Gh.H, et al.
Published: (2000-08-01)

The Fleet of Syracuse (480-413 BCE)
by: Andreas Morakis
Published: (2016-11-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Cancer neoantigen: Boosting immunotherapy
by: Peijia Xu, et al.
Published: (2020-11-01)

The Neoantigen Landscape of Mycosis Fungoides
by: Arunima Sivanand, et al.
Published: (2020-11-01)

Main Strategies for the Identification of Neoantigens
by: Alexander V. Gopanenko, et al.
Published: (2020-10-01)

The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01)

The Clinical Application of Neoantigens in Esophageal Cancer
by: Yi-Min Gu, et al.
Published: (2021-07-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
by: Wang Wanqiu
Published: (2019-01-01)

Neoantigen vaccine: an emerging tumor immunotherapy
by: Miao Peng, et al.
Published: (2019-08-01)

The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)

Structure Based Prediction of Neoantigen Immunogenicity
by: Timothy P. Riley, et al.
Published: (2019-08-01)

Progress in Neoantigen Targeted Cancer Immunotherapies
by: Xue-Jiao Han, et al.
Published: (2020-07-01)

Mutation-Derived Neoantigens for Cancer Immunotherapy
by: John C. Castle, et al.
Published: (2019-08-01)

m112b1f16_009
Published: ()

m94b3f16_009
Published: ()

m94b1f33_009
Published: ()

m112b1f2_009
Published: ()

Re‐evaluation of tragacanth (E 413) as a food additive
by: EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), et al.
Published: (2017-06-01)

Protein citrullination as a source of cancer neoantigens
by: Makoto Kobayashi, et al.
Published: (2021-06-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
by: Vladimir Roudko, et al.
Published: (2020-01-01)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
by: Malte Roerden, et al.
Published: (2019-12-01)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
by: Yugang Guo, et al.
Published: (2018-07-01)

The role of neoantigen in immune checkpoint blockade therapy
by: Ming Yi, et al.
Published: (2018-11-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
by: Zheying Zhang, et al.
Published: (2021-04-01)

Development of cancer nanovaccines based on glyco-neoantigens
by: Beatriz Gusmão Frango Teixeira
Published: (2021)

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
by: Joost H van den Berg, et al.
Published: (2020-07-01)

153 NEO-PTC-01 (BNT-221), an autologous neoantigen-specific T-cell product for adoptive cell therapy of metastatic melanoma
by: Michael Nelson, et al.
Published: (2020-11-01)

Ab initio atomistic thermodynamics of the (009) surface of strontium titanate
by: Liborio, L. M.
Published: (2006)

POS-009 PREVALENCE AND ETIOLOGIES OF ACUTE KIDNEY INJURY IN ELDERLY
by: S. Chargui, et al.
Published: (2021-04-01)

Clinical response and pathological evidence of treating metastatic breast cancer with immunotherapy using stimulated natural dendritic cell pulsed with neoantigen peptides
by: K. Chatamra, et al.
Published: (2021-04-01)

Analysis of the etiology and clinical characteristics in 1 413 cases of vitreous hemorrhage
by: Shu-Ping Jin, et al.
Published: (2021-09-01)

Validation of an HPLC method for the simultaneous determination of eletriptan and UK 120.413
by: Zečević Mira, et al.
Published: (2006-01-01)